If you have a bacterial infection, your healthcare provider may prescribe Factive. This medication is specifically approved to treat acute worsening of chronic bronchitis and mild-to-moderate, community-acquired pneumonia in adults. It works by interfering with bacteria's ability to multiply. A healthcare provider may also recommend using Factive off-label (for unapproved uses), such as for treating other types of bacterial infections.
Interested in a Discount on Factive?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Enter Your Email Address
Thank you!Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
Factive® (gemifloxacin mesylate) is a prescription antibiotic medication that belongs to a group of drugs called fluoroquinolones, or just "quinolones" for short. Factive is approved to treat the following types of infections:
- Acute worsening of chronic bronchitis
- Mild-to-moderate, community-acquired pneumonia.
Chronic bronchitis is a type of chronic obstructive pulmonary disease (COPD). COPD is a lung disease in which the lungs are damaged, leading to long-term breathing problems. With COPD, the airways (the tubes that carry air into and out of the lungs) are partly obstructed, making it difficult to breathe. Chronic bronchitis and emphysema are two kinds of COPD. While smoking is the most common cause, there are other possible causes of COPD.
Depending on the severity of your condition, your healthcare provider may recommend a number of drugs as part of your COPD treatment, including:
- Bronchodilators (medications to open the airways)
- Steroids (including inhaled steroids)
- Antibiotics, like Factive
Sometimes, people with chronic bronchitis experience a significant worsening of their symptoms. This is known as acute bronchitis. Factive is approved to treat these temporary symptoms. Specifically, it is approved to treat these exacerbations caused by the following bacteria:
- Streptococcus pneumoniae
- Haemophilus influenzae
- Haemophilus parainfluenzae
- Moraxella catarrhalis.